Access the full text.
Sign up today, get DeepDyve free for 14 days.
J. Dyson, N. Wilkinson, L. Jopson, G. Mells, G. Mells, A. Bathgate, Michael Heneghan, James Neuberger, Gideon Hirschfield, S. Ducker, Richard Sandford, Graeme Alexander, Deborah Stocken, Deborah Stocken, David Jones (2016)
The inter‐relationship of symptom severity and quality of life in 2055 patients with primary biliary cholangitisAlimentary Pharmacology & Therapeutics, 44
A. Jacoby, A. Rannard, D. Buck, N. Bhala, J. Newton, O. James, Dave Jones (2005)
Development, validation, and evaluation of the PBC-40, a disease specific health related quality of life measure for primary biliary cirrhosisGut, 54
K. Islam, S. Fukiya, Masahito Hagio, N. Fujii, S. Ishizuka, Tadasuke Ooka, Yoshitoshi Ogura, Tetsuya Hayashi, A. Yokota (2011)
Bile acid is a host factor that regulates the composition of the cecal microbiota in rats.Gastroenterology, 141 5
Ying Sun, Weici Zhang, Jilly Evans, A. Floreani, Z. Zou, Yukiko Nishio, Ruizhao Qi, P. Leung, C. Bowlus, M. Gershwin (2016)
Autotaxin, Pruritus and Primary Biliary Cholangitis (PBC).Autoimmunity reviews, 15 8
A. Baghdasaryan, C. Fuchs, C. Österreicher, U. Lemberger, E. Halilbasic, I. Påhlman, H. Graffner, E. Krones, P. Fickert, A. Wahlström, M. Ståhlman, G. Paumgartner, H. Marschall, M. Trauner (2016)
Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis.Journal of hepatology, 64 3
T. Midtvedt (1974)
Microbial bile acid transformation.The American journal of clinical nutrition, 27 11
J. Trottier, A. Białek, P. Caron, R. Straka, J. Heathcote, P. Milkiewicz, O. Barbier (2012)
Metabolomic profiling of 17 bile acids in serum from patients with primary biliary cirrhosis and primary sclerosing cholangitis: a pilot study.Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 44 4
G. Neale, B. Lewis, V. Weaver, D. Panveliwalla (1971)
Serum bile acids in liver diseaseGut, 12
V. Hegade, Stuart Kendrick, R. Dobbins, Sam Miller, D. Thompson, Duncan Richards, J. Storey, G. Dukes, M. Corrigan, R. Elferink, U. Beuers, G. Hirschfield, David Jones (2017)
Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a studyThe Lancet, 389
A. Miethke, Wujuan Zhang, Julia Simmons, Amy Taylor, Tiffany Shi, S. Shanmukhappa, Rebekah Karns, Shana White, Anil Jegga, Celine Lages, S. Nkinin, Bradley Keller, K. Setchell (2016)
Pharmacological inhibition of apical sodium‐dependent bile acid transporter changes bile composition and blocks progression of sclerosing cholangitis in multidrug resistance 2 knockout miceHepatology, 63
L. Lv, D. Fang, D. Shi, De-ying Chen, Ren Yan, Yi-Xin Zhu, Yanfei Chen, Li Shao, F. Guo, Wen-rui Wu, Ang Li, Haiyan Shi, Xia-wei Jiang, Huiyong Jiang, Yonghong Xiao, Shu-sen Zheng, Lanjuan Li (2016)
Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis.Environmental microbiology, 18 7
Sandrine Claus, T. Tsang, Yulan Wang, O. Cloarec, E. Skordi, F. Martin, S. Rezzi, Alastair Ross, S. Kochhar, E. Holmes, J. Nicholson (2008)
Systemic multicompartmental effects of the gut microbiome on mouse metabolic phenotypesMolecular Systems Biology, 4
V. Hegade, David Jones, G. Hirschfield (2017)
Apical Sodium-Dependent Transporter Inhibitors in Primary Biliary Cholangitis and Primary Sclerosing CholangitisDigestive Diseases, 35
Guías Clínica (1971)
European Association for the Study of the LiverGut, 12
N. Masubuchi, M. Sugihara, Tomonori Sugita, K. Amano, M. Nakano, T. Matsuura (2016)
Oxidative stress markers, secondary bile acids and sulfated bile acids classify the clinical liver injury type: Promising diagnostic biomarkers for cholestasis.Chemico-biological interactions, 255
G. Hirschfield, U. Beuers, C. Corpechot, P. Invernizzi, D. Jones, M. Marzioni, C. Schramm (2017)
EASL Clinical Practice Guidelines: The diagnosis and management of patients with primary biliary cholangitis.Journal of hepatology, 67 1
V. Hegade, Stuart Kendrick, R. Dobbins, Sam Miller, Duncan Richards, J. Storey, G. Dukes, K. Gilchrist, S. Vallow, G. Alexander, M. Corrigan, G. Hirschfield, David Jones (2016)
BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trialBMC Gastroenterology, 16
L. Bell, Jacob Wulff, M. Comerford, R. Vuppalanchi, N. Chalasani (2015)
Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitisLiver International, 35
P. Tandon, B. Rowe, B. Vandermeer, V. Bain (2007)
The Efficacy and Safety of Bile Acid Binding Agents, Opioid Antagonists, or Rifampin in the Treatment of Cholestasis-Associated PruritusThe American Journal of Gastroenterology, 102
You Li, R. Tang, P. Leung, M. Gershwin, Xiong Ma (2017)
Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases.Autoimmunity reviews, 16 9
Andreas Kremer, R. Dijk, P. Leckie, Frank Schaap, Edith Kuiper, T. Mettang, K. Reiners, U. Raap, H. Buuren, K. Erpecum, Nathan Davies, C. Rust, A. Engert, R. Jalan, R. Elferink, U. Beuers (2012)
Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventionsHepatology, 56
K. Nakamura, R. Ohkawa, S. Okubo, M. Tozuka, M. Okada, S. Aoki, J. Aoki, H. Arai, H. Ikeda, Y. Yatomi (2007)
Measurement of lysophospholipase D/autotaxin activity in human serum samples.Clinical biochemistry, 40 3-4
S. Al-Dury, A. Wahlström, S. Wahlin, Jacqueline Langedijk, R. Elferink, M. Ståhlman, H. Marschall (2018)
Pilot study with IBAT inhibitor A4250 for the treatment of cholestatic pruritus in primary biliary cholangitisScientific Reports, 8
J. Swann, E. Want, F. Geier, K. Spagou, I. Wilson, J. Sidaway, J. Nicholson, E. Holmes (2010)
Systemic gut microbial modulation of bile acid metabolism in host tissue compartmentsProceedings of the National Academy of Sciences, 108
A. Reig, Miriam Pérez-Cormenzana, P. Sesé, R. Mayo, A. Castro, A. Parés (2016)
Bezafibrate Alleviates Pruritus and Decreases Specific Circulating Metabolites in Patients with Primary Biliary CholangitisJournal of Hepatology, 64
M. Mayo, A. Wigg, B. Leggett, Hays Arnold, A. Thompson, M. Weltman, E. Carey, A. Muir, L. Ling, S. Rossi, A. DePaoli (2018)
NGM282 for Treatment of Patients With Primary Biliary Cholangitis: A Multicenter, Randomized, Double‐Blind, Placebo‐Controlled TrialHepatology Communications, 2
J. Herndon (1972)
Pathophysiology of pruritus associated with elevated bile acid levels in serum.Archives of internal medicine, 130 4
S. Elman, L. Hynan, V. Gabriel, M. Mayo (2010)
The 5‐D itch scale: a new measure of pruritusBritish Journal of Dermatology, 162
R. Tang, Yiran Wei, Yanmei Li, Weihua Chen, Haoyan Chen, Qixia Wang, Fan Yang, Q. Miao, Xiao Xiao, Haiyan Zhang, M. Lian, Xiang Jiang, Jun Zhang, Qin Cao, Z. Fan, Maoying Wu, D. Qiu, J. Fang, A. Ansari, M. Gershwin, Xiong Ma (2017)
Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapyGut, 67
Ying-mei Tang, Jia-ping Wang, Wei-min Bao, Jin-hui Yang, Lin-Kun Ma, Jing Yang, Hui-lin Chen, Ying Xu, Li-hong Yang, Wen Li, Yan-Ping Zhu, Jingjing Cheng (2015)
Urine and serum metabolomic profiling reveals that bile acids and carnitine may be potential biomarkers of primary biliary cirrhosisInternational Journal of Molecular Medicine, 36
Zhanyi Li, B. Lin, G. Lin, Yuankai Wu, Y. Jie, Xiangyong Li, B. Ko, Y. Chong, Jian Luo (2017)
Circulating FGF19 closely correlates with bile acid synthesis and cholestasis in patients with primary biliary cirrhosisPLoS ONE, 12
E. Holmes, A. Wijeyesekera, S. Taylor-Robinson, J. Nicholson (2015)
The promise of metabolic phenotyping in gastroenterology and hepatologyNature Reviews Gastroenterology &Hepatology, 12
M. Sarafian, M. Lewis, A. Pechlivanis, Simon Ralphs, M. Mcphail, V. Patel, M. Dumas, E. Holmes, J. Nicholson (2015)
Bile acid profiling and quantification in biofluids using ultra-performance liquid chromatography tandem mass spectrometry.Analytical chemistry, 87 19
D. Vandeputte, G. Falony, S. Vieira-Silva, R. Tito, M. Joossens, J. Raes (2015)
Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth ratesGut, 65
A. Kremer, J. Martens, W. Kulik, F. Ruëff, E. Kuiper, H. Buuren, K. Erpecum, J. Kondrackienė, J. Prieto, C. Rust, V. Geenes, C. Williamson, W. Moolenaar, U. Beuers, R. Elferink (2010)
Lysophosphatidic acid is a potential mediator of cholestatic pruritus.Gastroenterology, 139 3
Willem‐Jan Keune, Jens Hausmann, Ruth Bolier, D. Tolenaars, A. Kremer, T. Heidebrecht, R. Joosten, Manjula Sunkara, A. Morris, E. Matas-Rico, W. Moolenaar, R. Elferink, A. Perrakis (2016)
Steroid binding to Autotaxin links bile salts and lysophosphatidic acid signallingNature Communications, 7
M. Mayo, P. Pockros, D. Jones, C. Bowlus, C. Levy, I. Patanwala, B. Bacon, V. Luketic, R. Vuppalanchi, S. Medendorp, A. Dorenbaum, Ciara Kennedy, P. Novak, A. Raychaudhuri, S. Goyal, W. Abi-Saab, G. Hirschfield (2016)
Clarity: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Lopixibat Chloride (Formerly Lum001), a Novel Apical Sodium-Dependent Bile Acid Transporter Inhibitor, in the Treatment of Primary Biliary Cirrhosis Associated with ItchingJournal of Hepatology, 64
Jason Ridlon, Daejoong Kang, P. Hylemon, J. Bajaj (2014)
Bile acids and the gut microbiomeCurrent Opinion in Gastroenterology, 30
(2014)
Circulating bile acids and sterol levels in patients with cholestatic pruritus. Effects of albumin dialysis using Mars: 313
R. Sartor (2015)
Gut microbiota: Optimal sampling of the intestinal microbiota for researchNature Reviews Gastroenterology &Hepatology, 12
V. Hegade, G. Mells, H. Fisher, Stuart Kendrick, J. DiBello, K. Gilchrist, G. Alexander, G. Hirschfield, R. Sandford, David Jones (2019)
Pruritus Is Common and Undertreated in Patients With Primary Biliary Cholangitis in the United Kingdom.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 17 7
C. Padova, R. Tritapepe, P. Rovagnati, S. Rossetti (1984)
Double-blind placebo-controlled clinical trial of microporous cholestyramine in the treatment of intra- and extra-hepatic cholestasis: relationship between itching and serum bile acids.Methods and findings in experimental and clinical pharmacology, 6 12
Liver International – Wiley
Published: May 1, 2019
Keywords: ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.